• 1
    de Vries CS, van Diepen NM, Tromp TF, de Jong-van den Berg LT. Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists. Eur J Clin Pharmacol 1996; 50: 349352.
  • 2
    Fahey T, Sinclair H. Hospital initiated prescribing in the General Medical Services scheme. Ir Med J 1993; 86: 122124.
  • 3
    Robertson J, Fryer JL, O'Connell DL, Sprogis A, Henry DA. The impact of specialists on prescribing by general practitioners. Med J Aust 2001; 175: 407411.
  • 4
    Robertson J, Treloar CJ, Sprogis A, Henry DA. The influence of specialists on prescribing by GPs. A qualitative study. Aust Fam Physician 2003; 32: 573576.
  • 5
    Larsen J, Andersen M, Kragstrup J, Gram LF. Changes in the utilisation of lipid-lowering drugs over a 6-year period (1993–1998) in a Danish population. Eur J Clin Pharmacol 2001; 57: 343348.
  • 6
    De Smet PAGM, Dautzenberg M. Repeat prescribing: scale, problems and quality management in ambulatory care patients. Drugs 2004; 64: 17791800.
  • 7
    Feely J, Chan R, McManus J, O'Shea B. The influence of hospital-based prescribers on prescribing in general practice. Pharmacoeconomics. 1999; 16: 175181.
  • 8
    Bijl D, Van Sonderen E, Haaijer-Ruskamp FM. Prescription changes and drug costs at the interface between primary and specialist care. Eur J Clin Pharmacol 1998; 54: 333336.
  • 9
    McGettigan P, Golden J, Fryer J, Chan R, Feely J. Prescribers prefer people: the sources of information used by doctors for prescribing suggest that the medium is more important than the message. Br J Clin Pharmacol 2001; 51: 184189.
  • 10
    Strickland-Hodge B, Jepson MH. The role of the hospital consultant in general practitioner prescribing. J R Soc Med 1988; 81: 207209.
  • 11
    Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs – the importance of who says what. Fam Pract 2003; 20: 6168.
  • 12
    Schröder-Bernhardi D, Dietlein G. Lipid-lowering therapy: do hospitals influence the prescribing behavior of general practitioners? Int J Clin Pharmacol Ther 2002; 40: 317321.
  • 13
    Scherer M, Sobek C, Wetzel D, Koschack J, Kochen MM. Changes in heart failure medications in patients hospitalised and discharged. BMC Fam Pract 2006; 7: 6975.
  • 14
    Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther 2004; 42: 103109.
  • 15
    Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care–a large-scale follow-up study. Eur J Clin Pharmacol 2007; 63: 783790.
  • 16
    Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, Bianchi Porro G. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther 2003; 17: 15031506.
  • 17
    Zink DA, Pohlman M, Barnes M, Cannon ME. Long-term use of acid suppression started inappropriately during hospitalization. Aliment Pharmacol Ther 2005; 21: 12031209.
  • 18
    Krag A, Teglbjerg LS, Malchow-Møller A, Hallas J, Bytzer P. Prescribing of acid suppressive therapy: interactions between hospital and primary care. Aliment Pharmacol Ther 2006; 23: 17131718.
  • 19
    Müller-Bühl U, Gerold C, Engeser P, Szecsenyi J. Changes in drug therapy following hospital discharge for patients in a general practice: a German incident study. J Public Health. 2009; 17: 217223.
  • 20
    Fagnoni P, Limat S, Haffen E, Henon T, Jacquet M, Sechter D, Woronoff-Lemsi MC. Does hospitalisation affect hypnotic and anxiolytic drug prescribing? Pharm World Sci 2007; 29: 611618.
  • 21
    Edwards C, Bushnell JL, Ashton CH, Rawlins MD. Hospital prescribing and usage of hypnotics and anxiolytics. Br J Clin Pharmacol 1991; 31: 190192.
  • 22
    Gallini A, Juillard-Condat B, Saux M-C, Taboulet F. Drug selection in French university hospitals: analysis of formularies for nine competitive pharmacological classes. Br J Clin Pharmacol 2011; 72: 823831.
  • 23
    Pryce AJ, Heatlie HF, Chapman SR. Buccaling under the pressure: influence of secondary care establishments on the prescribing of glyceryl trinitrate buccal tablets in primary care. BMJ 1996; 313: 16211624.
  • 24
    Lapointe-Shaw L, Fischer HD, Newman A, John-Baptiste A, Anderson GM, Rochon PA, Bell CM. Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital. PLoS ONE 2012; 7: e39737.
  • 25
    World Health Organisation Collaborating Centre for Drug Statistics Methodology. 2008 ATC / DDD Index. Available at (last access 12 March 2012).
  • 26
    Stock JH, Yogo M. Testing for Weak Instruments in Linear IV Regression. National Bureau of Economic Research; 2002 Nov. Report No.: 284. Available at: (last access 12 March 2012).
  • 27
    Base Thériaque. Available at: (last access 12 March 2012).
  • 28
    Direction de la recherche, des études, de l'évaluation et des statistiques. 2010. Statistique annuelle des établissements de santé. Available at: (last access 12 March 2012).
  • 29
    Institut de recherche et de documentation en économie de la santé. 2010. Eco-Santé databases. Available at: (last access 12 March 2012).
  • 30
    Evain F, Minodier C. Les centres hospitaliers universitaires: entre activité de pointe et activité de proximité. Un essai de typologie. Les établissements de santé – Un panorama pour l'année 2007. DREES; 2010. p. 1129.
  • 31
    Sermet C, Andrieu V, Godman B, Van Ganse E, Haycox A, Reynier J. Ongoing pharmaceutical reforms in France: implications for key stakeholder groups. Appl Health Econ Health Policy 2010; 8: 724.
  • 32
    Inspection générale des affaires sociales. 2007. L'information des médecins généralistes sur le médicament. Available at: (last access 12 March 2012).